ADH-1 (proposed brand name Exherin) is a cyclic peptide antineoplastic drug developed by Adherex Technologies.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.